Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
FRPT has bounced nearly 10% this week to $63.25, but the short interest is holding firm and options traders are the most defensive they have been in months, a combination that frames the November 2 earnings date as the clearest near-term test.
Short sellers are not rushing to cover. Short interest stands at 15.7% of the free float, roughly 7.65 million shares, and has edged up about 0.2% on the week after climbing 4.7% over the past month. The direction of travel is gradual accumulation, not panic or a rapid squeeze. The borrow market reflects that patience: the cost to borrow is a modest 0.47%, barely inconvenient even after rising 19% on the week. Availability is also comfortable at 328%, meaning roughly three shares are available for every one already borrowed. There is no mechanical squeeze pressure here.
What is more telling this week is the shift in options positioning. The put/call ratio has moved to 0.77, more than two standard deviations above its 20-day average of 0.65, the most defensive reading in months. That is a meaningful jump for a stock that just rallied 10% in a week. It suggests that buyers of the recent move are hedging it rather than pressing it, reaching for downside protection even as the price recovers. The PCR's 52-week range runs from 0.47 to 1.82, so the current reading is elevated but not at extremes. The picture is caution, not panic.
The Street is broadly constructive but trimming ambitions. The mean price target sits at $83.94, roughly 33% above the current price. Most recent action has been bearish on targets, however: Wells Fargo cut its target to $77 from $82 this week while keeping an Overweight rating. Morgan Stanley downgraded to Equal-Weight in August, trimming its target to $72. The bull case from analysts centres on the still-underpenetrated refrigerated dog food category, where distribution gains at Costco, Walmart and Tractor Supply could drive household penetration toward 18%, with gross margin expanding toward 49% and EBITDA margin near 20% by 2027. The bear case is sharper: Blue Buffalo and Kirkland's entry into the refrigerated segment, slowing household growth, elevated acquisition costs, and input cost pressure could all combine to leave margins and revenue short of those targets. The factor scores add nuance. EPS surprise ranks in the 93rd percentile of the universe, and 90-day EPS momentum sits at the 80th percentile, suggesting the company has been beating expectations. But the forward earnings yield picture is weak, with the 12-month forward EPS year-on-year increase factor in the 7th percentile. The EV/EBITDA multiple is 12.9x, little changed over 30 days.
One detail worth flagging on insider activity: the 90-day net across all insiders is negative $16 million, but that figure is dominated by the CEO's August option exercises and associated open-market sales, all executed under a pre-arranged 10b5-1 plan. Planned sales under 10b5-1 programmes carry far less signal than discretionary ones. The one genuinely discretionary trade in the recent window is a director's open-market purchase of 1,000 shares at $64.92 on September 14, a small but unscripted vote of confidence near current levels. Institutional ownership is broadly stable. BlackRock holds 12.2% as of September 30, and Wellington added around 298,000 shares in its latest reported period.
Retail attention is running elevated. The ORTEX Wikipedia-views signal, which tracks English Wikipedia article views and ORTEX stock page visitors against Freshpet's own 90-day history, shows a z-score of 2.18 as of late September. That is attention, not a revenue indicator, but it does suggest the name is drawing more eyes than usual, possibly connected to the competitive news around private-label refrigerated pet food and the stock's sharp month-long decline before this week's bounce.
The previous two earnings prints rewarded holders: the August 2026 report produced a 7% one-day gain and a 16% five-day move. The Q1 print earlier in the year added about 5% on the day and 14% over the following week. With 25 days to the November 2 report, what to watch is whether the defensive options positioning resolves or deepens as the print approaches, and whether short interest continues its slow grind higher or begins to retreat if the stock consolidates above $60.
See the live data behind this article on ORTEX.
Open FRPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
